WHO Issues New Clinical Advice on Treating COVID-19 Patients

World Health Organization (WHO) has issued new clinical advice regarding the treatment of COVID-19 patients, including those exhibiting persistent symptoms after recovery.

While addressing a media briefing, WHO spokesperson Margaret Harris advised healthcare authorities to use low-dose anticoagulants to prevent blood clotting among COVID-19 patients.


Universities Academic Staff Association Rejects HEC’s New Policy for PhD Admissions

She added that low-dose anticoagulants have been recommended because high-dose anticoagulants can result in other problems aside from preventing blood clotting.

The international public health agency has recommended pulse oximetry for Coronavirus patients being treated at homes. Pulse oximetry is a non-invasive and painless test that measures oxygen levels in the blood.


Pakistan Exposes India’s Lies by Securing GI Tag for Basmati Rice

Margaret Harris also revealed that a WHO-led team of independent experts is in Wuhan, where the first case of COVID-19 was detected in December 2019.

The WHO-led team in collaboration with Chinese researchers will soon start research to determine the origin of the Coronavirus.